SGLT2 Inhibitors Address Cardiovascular, Kidney, and Hypertension Risks

"After 33 years of diabetes practice, we must change our approach. It's no longer just about controlling blood sugar; it's about addressing cardiovascular, kidney, and liver health too," said Dr. Vijay Vishwanathan in a conversation with Dr. PC Manoria at the Third World Congress on Cardiometabolic Medicine (WCCMM) 2024.


Top 5 Takeaways from the Conversation

1. Diabetes Care Prioritizes Cardiovascular, Renal, and Metabolic Health
2. SGLT2 Inhibitors Effectively Address Heart, Kidney, and Liver Risks
3. GLP1 Receptor Agonists Offer a Strong Alternative for Risk Reduction
4. Early Pre-Diabetes Intervention Prevents Severe Complications
5. Continuous Glucose Monitoring (CGM) Is Crucial for Managing Glycemic Variability

Dr. Vijay Vishwanathan
Dr. Vijay Vishwanathan is the President-Elect of the Research Society for the Study of Diabetes in India (RSSDI) and a globally acclaimed expert in diabetes care with over 33 years of clinical experience. He is the Chief Diabetologist and Head of M.V. Hospital for Diabetes, Chennai. Dr. Vishwanathan specializes in the early detection and management of diabetes complications such as nephropathy, neuropathy, cardiovascular disease, and non-alcoholic fatty liver disease (NAFLD). A prolific researcher and author, he has conducted groundbreaking studies, including work on the prevalence of tuberculosis in prediabetic patients. He is a strong proponent of advanced therapies, including Sodium-Glucose Co-Transporter 2 (SGLT2) inhibitors and Glucagon-Like Peptide-1 (GLP-1) receptor agonists, and champions the integration of Continuous Glucose Monitoring (CGM) to optimize patient outcomes.
LinkedIn: https://www.linkedin.com/in/vijay-vis...

Website: https://iwgdfguidelines.org/viswanathan/

Dr. P.C. Manoria
Dr. P.C. Manoria is a distinguished cardiologist based in Bhopal, India, renowned for his extensive experience and contributions to cardiac care. He operates the Manoria Heart & Critical Care Hospital, where he has been instrumental in advancing cardiac treatment in the region. Dr. Manoria has earned a reputation for his compassionate patient care and expertise in cardiology, making significant strides in the management of heart diseases. His dedication to improving patient outcomes is reflected in the high regard his colleagues and patients have for him, often highlighting his thoroughness and commitment to excellence in medical practice.
In addition to his clinical work, Dr. Manoria is actively involved in medical education and research, participating in various conferences and seminars to share knowledge on advancements in cardiology.

Website: https://www.emedevents.com/speaker-pr...


(0:00) WCCMM Starting Montage
(0:28) Introduction
(0:46) The Role of SGLT2 Inhibitors in Diabetes Management
(2:56) Early Intervention in Pre-Diabetes to Improve Outcomes
(3:46) GLP-1 Receptor Agonists in Reducing ASCVD Events
(4:31) Combining SGLT2 and GLP-1 for Multiple Comorbidities
(5:29) Contribution Of CGM In Glycemic Control
(6:51) Ending Montage

#WCCMM2024 #DrVijayVishwanathan #DrPCManoria #ManoriaHeartHospital #MVHospitalForDiabetes #DiabetesCare #SGLT2Inhibitors #GLP1ReceptorAgonists #CardiorenalMetabolicImprovement #GlycemicControl #CGM #PreDiabetes #DiabetesManagement #GlycemicVariability #TheRightDoctors #TRD
India's leading Medical Knowledge platform, TheRightDoctors, is a Google Launchpad Digital Health StartUp. We bring Insights from the World's Best Medical Minds to audiences worldwide.

Our recognitions:
Google Launchpad (USD200,000 in platform credit over two tranches), Berlin Bootcamp, Startup Networkz Singapore (Start-Up of Substance), and NASSCOM Showcase Start-Up.

Subscribe for more videos: https://bit.ly/2X2gQmF

Our Social Media Links:
Facebook - https://goo.gl/YO1oel
Twitter - https://goo.gl/J1gtvw
LinkedIn - https://bit.ly/368sfGb
Web - https://bit.ly/36qI3ma

#TheRightDoctors #TRD

© TheRightDoctors Knowledge Network. All rights reserved.